Steinmueller, Sophie A MFender, JuliaDeventer, Marie HTutov, AnnaLorenz, KristinaStove, Christophe PHislop, JamesDecker, Michael2024-02-232024-02-232023-12-04Steinmueller, S A M, Fender, J, Deventer, M H, Tutov, A, Lorenz, K, Stove, C P, Hislop, J & Decker, M 2023, 'Visible-Light Photoswitchable Benzimidazole Azo-Arenes as beta-Arrestin2-Biased Selective Cannabinoid 2 Receptor Agonists', Angewandte Chemie International Edition, vol. 62, no. 49, e202306176. https://doi.org/10.1002/anie.2023061761433-7851unpaywall: 10.1002/anie.202306176https://hdl.handle.net/2164/22835Acknowledgements The authors would like to acknowledge Dr. Andrea Holme for excellent technical support and the Iain Fraser Cytometry Centre (University of Aberdeen) for providing access to their equipment. The authors would like to thank Dr. Matthias Scheiner for his contributions towards the development of the calcium mobilization assay and Dr. Valérie Jahns for her efforts towards faster automated analysis of the obtained results. Nick Verhavert is acknowledged for his assistance with the NanoBiT® assay. Diego Rodriguez-Soacha is acknowledged for establishing the rCB1R radioligand binding assay in our laboratory. Special thanks to Dr. Rangan Maitra and RTI International for providing the G16 coupled hCB1 and hCB2 CHO-K1 cell lines. The authors thank Nadine Yurdagül-Hemmrich and Annette Hannawacker for excellent technical support.111578258engbenzimidazolesG protein-coupled receptoroptical controlphotopharmacologybiased ligandR MedicineSupplementary DataRVisible-Light Photoswitchable Benzimidazole Azo-Arenes as beta-Arrestin2-Biased Selective Cannabinoid 2 Receptor AgonistsJournal article10.1002/anie.2023061766249